International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | £240 | £260 | £261 | £268 |
| - Cash | £15 | £10 | £0 | £0 |
| + Debt | £30 | £23 | £32 | £40 |
| Enterprise Value | £254 | £272 | £294 | £308 |
| Revenue | £19 | £42 | £8 | £22 |
| % Growth | -55.9% | 398.4% | -61.6% | – |
| Gross Profit | £14 | £40 | £6 | -£14 |
| % Margin | 77% | 94.8% | 72.6% | -61.3% |
| EBITDA | -£0 | £40 | £0 | £0 |
| % Margin | -0.1% | 93.4% | 0% | 0% |
| Net Income | -£1 | £39 | £7 | -£22 |
| % Margin | -6.3% | 91.8% | 80.2% | -101.5% |
| EPS Diluted | -0.033 | 1.02 | 0.17 | -0.55 |
| % Growth | -103.2% | 500% | 130.9% | – |
| Operating Cash Flow | £29 | £45 | £27 | £1 |
| Capital Expenditures | -£29 | £0 | £0 | £0 |
| Free Cash Flow | £0 | £45 | £27 | £1 |